CDK2 and cancer: Furthermore, this study intends to computationally assess and predict the drug-likeness of chemical classes in the H. splendidum metabolome, the molecular interaction between the proteins CDK-2 (cyclin-dependent kinase 2) and CCNB1 (cyclin B1) (involved in in the development and progression of cancer), and the inhibitors (ligands) identified in the plant’s extracts.